1Buhl R, Farmer SG. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthlna[J]. Proc Am Thorac Soc,2004, 1 : 136 - 142.
2Sharma S, Anthonisen N. Role of antimicrobial agents in the management of exacerbations of COPD[J]. Treat Respir Meal,2005,4:153 - 167.
3Miravitlles M, Torres A. No more equivalenee trials for antibiotics in exacerbations of COPD[J]. Chest,2004,125:811 -813.
4Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations[J]. Chest, 1995,108 : S43 - S52.
5Hunter MH, King DE. COPD: Management of acute exacerbations and chronic stable disease[J].Am Fam Physician,2001,64:603-612.
6Sethi S. Infectious etiology of acute exacerbation of chronic bronchitis [J]. Chest,2000,117 (5 Suppl 2) :380S - 385S.
7Soler N, Tortes A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation[J]. Am J Respir Crit Care Med, 1998,157:1498- 1505.
8Miravitlles M, Espinosa C, Fernandez - Laso E, et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD [J]. Chest, 1999,116:40 - 46.
9Eller J, Ede A, Schaberg T, et al. Infective exacerbations of chronic bronchitis. Relation between bacterial etiology and lung function[J]. Chest, 1998,113 : 1542 - 1548.
10Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)[J]. Am J Respir Crit Care Med, 1996,154(4) :959 - 967.
6Kou m is T,Sa muel S.Tiot ropiu m brom ide:a new long-actingbronchodilator for the treatment of chronic obstructivepulmonary disease[J].Clin Ther,2005,27(4):377-392.
